Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
783.83
810.21
761.04
565.06
404.50
305.65
240.58
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
783.83
810.21
761.04
565.06
404.50
305.65
240.58
Raw Material Cost
375.77
378.28
383.03
266.96
186.91
155.09
141.11
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
184.95
169.30
0.00
112.01
85.52
65.65
57.39
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
8.03
8.27
6.55
1.88
1.60
2.71
3.21
Selling and Distribution Expenses
124.62
113.55
111.09
79.22
59.40
54.54
43.02
Other Expenses
-9.85
-10.54
5.49
-5.09
-4.12
-2.44
-2.97
Total Expenditure (Excl Depreciation)
594.87
563.96
555.58
409.18
292.19
253.64
214.99
Operating Profit (PBDIT) excl Other Income
189
246.20000000000002
205.5
155.9
112.30000000000001
52
25.6
Other Income
63.17
62.53
53.79
-4.22
-5.72
19.57
25.18
Operating Profit (PBDIT)
306.39
344.12
291.94
177.97
127.76
86.36
68.87
Interest
8.03
8.27
6.55
1.88
1.60
2.71
3.21
Exceptional Items
5.50
-4.49
4.95
13.33
-5.23
-0.32
2.37
Gross Profit (PBDT)
408.07
431.92
378.00
298.10
217.58
150.57
99.46
Depreciation
63.66
40.59
34.48
30.02
25.43
22.73
20.70
Profit Before Tax
240.20
290.76
255.86
159.39
95.50
60.60
47.32
Tax
33.41
36.86
20.48
13.46
8.66
4.22
3.46
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
206.79
253.90
235.38
145.93
86.84
56.39
43.86
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
206.79
253.90
235.38
145.93
86.84
56.39
43.86
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
206.79
253.90
235.38
145.93
86.84
56.39
43.86
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,271.89
2,141.58
1,461.14
1,254.82
1,126.88
645.19
597.60
Earnings per share (EPS)
0.25
0.31
0.3
0.19
0.12
0.08
0.06
Diluted Earnings per share
0.25
0.31
0.3
0.19
0.12
0.08
0.06
Operating Profit Margin (Excl OI)
22.91%
29.74%
26.76%
26.93%
26.71%
14.41%
9.55%
Gross Profit Margin
38.77%
40.9%
38.15%
33.52%
29.89%
27.26%
28.28%
PAT Margin
26.38%
31.34%
30.93%
25.83%
21.47%
18.45%
18.23%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is -3.26% vs 6.47% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is -18.55% vs 7.86% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is -13.64% vs 18.27% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is -3.61% vs 25.76% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has fallen from Dec 2023
Compare Annual Results Of Zhejiang Ausun Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
783.83
0
783.83
Other Operating Income
0.00
0.00
0.00
Total Operating income
783.83
0
783.83
Raw Material Cost
375.77
0
375.77
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
184.95
0
184.95
Power Cost
0
0
0.00
Manufacturing Expenses
8.03
0
8.03
Selling and Distribution Expenses
124.62
0
124.62
Other Expenses
-9.85
0.00
-9.85
Total Expenditure (Excl Depreciation)
594.87
0
594.87
Operating Profit (PBDIT) excl Other Income
188.97
0.00
188.97
Other Income
63.17
0
63.17
Operating Profit (PBDIT)
306.39
0
306.39
Interest
8.03
0
8.03
Exceptional Items
5.50
0
5.50
Gross Profit (PBDT)
408.07
0
408.07
Depreciation
63.66
0
63.66
Profit Before Tax
240.20
0
240.20
Tax
33.41
0
33.41
Provisions and contingencies
0
0
0.00
Profit After Tax
206.79
0
206.79
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
206.79
0
206.79
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
206.79
0
206.79
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,271.89
0
2,271.89
Earnings per share (EPS)
0.25
0
0.25
Diluted Earnings per share
0.25
0
0.25
Operating Profit Margin (Excl OI)
22.91%
0%
0.00
22.91%
Gross Profit Margin
38.77%
0%
0.00
38.77%
PAT Margin
26.38%
0%
0.00
26.38%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 78.38 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -3.26% vs 6.47% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 20.68 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -18.55% vs 7.86% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 24.32 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -13.64% vs 18.27% in Dec 2023
Annual - Interest
Interest 0.80 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -3.61% vs 25.76% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 22.91%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has fallen from Dec 2023






